Bioventus (BVS) Short term Debt (2020 - 2026)

Bioventus (BVS) has 7 years of Short term Debt data on file, last reported at $18.8 million in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt rose 77.34% year-over-year to $18.8 million; the trailing twelve-month figure through Mar 2026 stood at $18.8 million (up 77.34% YoY), and the FY2025 full-year result was $15.0 million, down 23.36% from the prior year.
• Short term Debt for Q1 2026 stood at $18.8 million, up from $15.0 million in the prior quarter.
• Across five years, Short term Debt topped out at $43.4 million in Q2 2025 and bottomed at $10.6 million in Q1 2025.
• The 5-year median for Short term Debt is $19.6 million (2023), against an average of $23.2 million.
• Peak annual rise in Short term Debt reached 131.3% in 2025, while the deepest fall reached 70.48% in 2025.
• A 5-year view of Short term Debt shows it stood at $33.1 million in 2022, then slumped by 40.76% to $19.6 million in 2023, then slipped by 0.06% to $19.6 million in 2024, then retreated by 23.36% to $15.0 million in 2025, then grew by 25.0% to $18.8 million in 2026.
• The last three Short term Debt figures came in at $18.8 million (Q1 2026), $15.0 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.

Peer Comparison